drugset / Trial / NCT00289887

Obese Hypertension Study (0954-315)

NCT00289887

Phase 3 Completed 261 enrolled Organon and Co
RandomizedParallel-groupDouble-blindTreatment

Summary

This is a 16-week study to evaluate high systolic and diastolic blood pressure following treatment in obese, hypertensive, adult patients.

Timeline

Start
2006-02
Primary completion
2007-02
Completion
2007-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Hydrochlorothiazide Unknown 25 mg
Subject Losartan Other / unclassified 100 mg

Indications